chr2-21003346-GA-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000384.3(APOB):c.12088-13delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0123 in 1,174,020 control chromosomes in the GnomAD database, including 31 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0036 ( 5 hom., cov: 32)
Exomes 𝑓: 0.013 ( 26 hom. )
Consequence
APOB
NM_000384.3 intron
NM_000384.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.342
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-21003346-GA-G is Benign according to our data. Variant chr2-21003346-GA-G is described in ClinVar as [Benign]. Clinvar id is 490382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-21003346-GA-G is described in Lovd as [Benign]. Variant chr2-21003346-GA-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00358 (493/137590) while in subpopulation EAS AF = 0.0426 (205/4808). AF 95% confidence interval is 0.0379. There are 5 homozygotes in GnomAd4. There are 252 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,SD,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00357 AC: 491AN: 137524Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
491
AN:
137524
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0184 AC: 2615AN: 141744 AF XY: 0.0180 show subpopulations
GnomAD2 exomes
AF:
AC:
2615
AN:
141744
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0134 AC: 13904AN: 1036430Hom.: 26 Cov.: 29 AF XY: 0.0131 AC XY: 6722AN XY: 513868 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
13904
AN:
1036430
Hom.:
Cov.:
29
AF XY:
AC XY:
6722
AN XY:
513868
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
293
AN:
22828
American (AMR)
AF:
AC:
316
AN:
29532
Ashkenazi Jewish (ASJ)
AF:
AC:
254
AN:
17156
East Asian (EAS)
AF:
AC:
1491
AN:
27616
South Asian (SAS)
AF:
AC:
676
AN:
58098
European-Finnish (FIN)
AF:
AC:
393
AN:
33870
Middle Eastern (MID)
AF:
AC:
58
AN:
4374
European-Non Finnish (NFE)
AF:
AC:
9747
AN:
801148
Other (OTH)
AF:
AC:
676
AN:
41808
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.319
Heterozygous variant carriers
0
1564
3127
4691
6254
7818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00358 AC: 493AN: 137590Hom.: 5 Cov.: 32 AF XY: 0.00379 AC XY: 252AN XY: 66410 show subpopulations
GnomAD4 genome
AF:
AC:
493
AN:
137590
Hom.:
Cov.:
32
AF XY:
AC XY:
252
AN XY:
66410
show subpopulations
African (AFR)
AF:
AC:
92
AN:
37500
American (AMR)
AF:
AC:
32
AN:
13834
Ashkenazi Jewish (ASJ)
AF:
AC:
21
AN:
3250
East Asian (EAS)
AF:
AC:
205
AN:
4808
South Asian (SAS)
AF:
AC:
12
AN:
4390
European-Finnish (FIN)
AF:
AC:
4
AN:
7852
Middle Eastern (MID)
AF:
AC:
4
AN:
266
European-Non Finnish (NFE)
AF:
AC:
108
AN:
62934
Other (OTH)
AF:
AC:
15
AN:
1918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypercholesterolemia, familial, 1 Benign:1
Aug 28, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Sep 13, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at